{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:33:21Z","timestamp":1766486001813,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH\/NCI Cancer Center","award":["P30 CA00874"],"award-info":[{"award-number":["P30 CA00874"]}]},{"name":"Brownstein Fund"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbmt.2018.04.013","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:38:37Z","timestamp":1524019117000},"page":"1914-1919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9484-0240","authenticated-orcid":false,"given":"Michael","family":"Scordo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sejal M.","family":"Morjaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Littmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankush","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen H.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Maloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1944-5053","authenticated-orcid":false,"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Taur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig S.","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.bbmt.2018.04.013_bib0010","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2007.13.5533","article-title":"Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Soci\u00e9t\u00e9 Fran\u00e7aise de Greffe de Mo\u00eblle Osseuse-Th\u00e9rapie Cellulaire","volume":"26","author":"Soussain","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.bbmt.2018.04.013_bib0015","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbmt.2011.07.006","article-title":"Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma","volume":"18","author":"Cote","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.04.013_bib0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/10428194.2014.916800","article-title":"Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide","volume":"56","author":"Welch","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.bbmt.2018.04.013_bib0025","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2014-10-604561","article-title":"R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma","volume":"125","author":"Omuro","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bbmt.2018.04.013_bib0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbmt.2016.09.024","article-title":"A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning","volume":"23","author":"Scordo","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"10.1016\/j.bbmt.2018.04.013_bib0035","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/cncr.30695","article-title":"High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission","volume":"123","author":"DeFilipp","year":"2017","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bbmt.2018.04.013_bib0040","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clml.2017.08.100","article-title":"High-dose thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation as upfront consolidation for systemic non-Hodgkin lymphoma with synchronous central nervous system involvement","volume":"17","author":"Qualls","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"10.1016\/j.bbmt.2018.04.013_bib0045","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bbmt.2018.04.013_bib0050","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.bbmt.2018.04.013_bib0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/tid.12022","article-title":"European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: Summary of ECIL-4 (2011)","volume":"14","author":"Matthes-Martin","year":"2012","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.bbmt.2018.04.013_bib0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.bbmt.2018.04.013_bib0065","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bbmt.2018.04.013_bib0070","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/bmt.2009.258","article-title":"Viral disease prevention after hematopoietic cell transplantation","volume":"44","author":"Zaia","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2018.04.013_bib0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1701827","article-title":"Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance","volume":"24","author":"Bilgrami","year":"1999","journal-title":"Bone Marrow Transpl"},{"issue":"1","key":"10.1016\/j.bbmt.2018.04.013_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2141.2001.02487.x","article-title":"Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: High rates of reactivation in patients with multiple myeloma and lymphoma","volume":"112","author":"Fassas","year":"2001","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bbmt.2018.04.013_bib0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5500\/wjt.v5.i3.129","article-title":"Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: a single-center study","volume":"5","author":"Marchesi","year":"2015","journal-title":"World J Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.04.013_bib0090","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jmv.24621","article-title":"Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay","volume":"89","author":"Inazawa","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.bbmt.2018.04.013_bib0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2015.1.215","article-title":"Immune reconstitution following stem cell transplantation","volume":"2015","author":"van den Brink","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"issue":"6","key":"10.1016\/j.bbmt.2018.04.013_bib0100","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbmt.2015.02.005","article-title":"Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation","volume":"21","author":"Chen","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"10.1016\/j.bbmt.2018.04.013_bib0105","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","article-title":"Lymphoma","volume":"35","author":"Grommes","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bbmt.2018.04.013_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002025","article-title":"Steroid-based therapy and risk of infectious complications","volume":"13","author":"Rostaing","year":"2016","journal-title":"PLoS Med"},{"issue":"23","key":"10.1016\/j.bbmt.2018.04.013_bib0115","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1182\/blood-2016-06-724005","article-title":"Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution","volume":"128","author":"De Koning","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbmt.2018.04.013_bib0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","article-title":"Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 Years' experience of infection in GIMEMA centres","volume":"117","author":"Pagano","year":"2002","journal-title":"Br J Haematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118301940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118301940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:04:02Z","timestamp":1761059042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118301940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1083879118301940"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.04.013","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinctive Infectious Complications in Patients with Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide-conditioned Autologous Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}